214 related articles for article (PubMed ID: 20399695)
1. Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of Tipranavir analogs for HIV protease inhibition.
Reddy AS; Kumar S; Garg R
J Mol Graph Model; 2010 Jun; 28(8):852-62. PubMed ID: 20399695
[TBL] [Abstract][Full Text] [Related]
2. Selection of molecular descriptors with artificial intelligence for the understanding of HIV-1 protease peptidomimetic inhibitors-activity.
Sirois S; Tsoukas CM; Chou KC; Wei D; Boucher C; Hatzakis GE
Med Chem; 2005 Mar; 1(2):173-84. PubMed ID: 16787312
[TBL] [Abstract][Full Text] [Related]
3. QSAR studies on HIV-1 protease inhibitors using non-linearly transformed descriptors.
Saranya N; Selvaraj S
Curr Comput Aided Drug Des; 2012 Mar; 8(1):10-49. PubMed ID: 21999608
[TBL] [Abstract][Full Text] [Related]
4. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
5. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method.
Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):844-53. PubMed ID: 20429783
[TBL] [Abstract][Full Text] [Related]
7. Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism.
Santos-Filho OA; Hopfinger AJ
J Chem Inf Model; 2006; 46(1):345-54. PubMed ID: 16426069
[TBL] [Abstract][Full Text] [Related]
8. Development of anti-HIV activity models of lysine sulfonamide analogs: a QSAR perspective.
Muthukumaran R; Sangeetha B; Amutha R; Mathur PP
Curr Comput Aided Drug Des; 2012 Mar; 8(1):70-82. PubMed ID: 21999609
[TBL] [Abstract][Full Text] [Related]
9. QSAR studies of bioactivities of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 receptor ligands using physicochemical descriptors and MLR and ANN-modeling.
Goodarzi M; Freitas MP; Ghasemi N
Eur J Med Chem; 2010 Sep; 45(9):3911-5. PubMed ID: 20547432
[TBL] [Abstract][Full Text] [Related]
10. Particle swarm optimization and genetic algorithm as feature selection techniques for the QSAR modeling of imidazo[1,5-a]pyrido[3,2-e]pyrazines, inhibitors of phosphodiesterase 10A.
Goodarzi M; Saeys W; Deeb O; Pieters S; Vander Heyden Y
Chem Biol Drug Des; 2013 Dec; 82(6):685-96. PubMed ID: 23906083
[TBL] [Abstract][Full Text] [Related]
11. Developing a methodology for an inverse quantitative structure-activity relationship using the signature molecular descriptor.
Visco DP; Pophale RS; Rintoul MD; Faulon JL
J Mol Graph Model; 2002 Jun; 20(6):429-38. PubMed ID: 12071277
[TBL] [Abstract][Full Text] [Related]
12. A self-adaptive genetic algorithm-artificial neural network algorithm with leave-one-out cross validation for descriptor selection in QSAR study.
Wu J; Mei J; Wen S; Liao S; Chen J; Shen Y
J Comput Chem; 2010 Jul; 31(10):1956-68. PubMed ID: 20512843
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
[TBL] [Abstract][Full Text] [Related]
14. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
15. Inhibition activity prediction for a dataset of candidates' drug by combining fuzzy logic with MLR/ANN QSAR models.
Abdolmaleki A; Ghasemi JB
Chem Biol Drug Des; 2019 Jun; 93(6):1139-1157. PubMed ID: 31343121
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel HIV-1 Integrase Inhibitors Using QSAR-Based Virtual Screening of the NCI Open Database.
Ko GM; Garg R; Bailey BA; Kumar S
Curr Comput Aided Drug Des; 2016; 12(2):135-53. PubMed ID: 27076270
[TBL] [Abstract][Full Text] [Related]
18. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.
Ahmadi S; Ganji S
Curr Drug Discov Technol; 2016; 13(4):232-253. PubMed ID: 27457492
[TBL] [Abstract][Full Text] [Related]
19. QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection.
Ghosh P; Bagchi MC
Curr Med Chem; 2009; 16(30):4032-48. PubMed ID: 19747124
[TBL] [Abstract][Full Text] [Related]
20. A genetic algorithm optimized fuzzy neural network analysis of the affinity of inhibitors for HIV-1 protease.
Fabry-Asztalos L; Andonie R; Collar CJ; Abdul-Wahid S; Salim N
Bioorg Med Chem; 2008 Mar; 16(6):2903-11. PubMed ID: 18194868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
